SCYNEXIS to Present at the 29th Annual Piper Jaffray Healthcare Conference

JERSEY CITY, N.J., Nov. 22, 2017 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative anti-infective therapies for difficult-to-treat and often life-threatening infections, today announced that the Company will present at the 29th Annual Piper Jaffray Healthcare Conference at the Lotte New York Palace Hotel on Tuesday, November 28, 2017 at 1:00 p.m. ET.

A live webcast will be available on the investors section of the Company's website: www.SCYNEXIS.com. A replay of the presentation will be available approximately two hours after the event and will be available for two weeks following the presentation.

About SCYNEXIS
SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas. The Company's lead product candidate, SCY-078, is the first representative of a novel intravenous and oral triterpenoid antifungal family and is in Phase 2 clinical development for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections.  For more information, visit www.scynexis.com.

CONTACT:

Media Relations
Cammy Duong
MacDougall Biomedical Communications
Tel: [phone]
[e-mail]

Investor Relations
Susan Kim
Argot Partners
Tel: [phone]
[e-mail]

 

View original content:http://www.prnewswire.com/news-releases/scynexis-to-present-at-the-29th-annual-piper-jaffray-healthcare-conference-300560738.html

SOURCE SCYNEXIS, Inc.

Copyright 2017 PR Newswire